Mrs. Rebecca Lynn Webb, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2949 Erie Blvd E, Suite 103, Syracuse, NY 13224 Phone: 315-425-8028 Fax: 315-425-0989 |
Tiffany Vondeak, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3325 W Genesee St, Syracuse, NY 13219 Phone: 315-487-1585 Fax: 315-487-1916 |
Mr. Michael John Heaton, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Syracuse, NY 13210 Phone: 315-425-2456 |
Mr. Stuart Jay Sloane, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4713 Onondaga, Syracuse, NY 13219 Phone: 315-472-3832 Fax: 315-472-4131 |
Mr. Arthur L Daley Iii, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 736 Irving Ave, Syracuse, NY 13210 Phone: 315-470-7631 Fax: 315-470-2601 |
Dr. Christine Mary Stork-medicis, PHARM.D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-5421 Fax: 315-464-7077 |
Megan Terese Newkirk, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Syracuse, NY 13210 Phone: 315-425-4400 |
Mr. Korey Harold Willard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Syracuse, NY 13045 Phone: 315-425-4400 |
Ms. Karen S Whitney, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 620 Madison Street, Syracuse, NY 13210 Phone: 315-426-6836 Fax: 315-426-6801 |
Danielle R Delvecchio, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4210 |
Dr. Stephanie M Wiemeier, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 736 Irving Ave, Syracuse, NY 13210 Phone: 315-470-7631 |
Steven Paul Moshinskie, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Syracuse, NY 13210 Phone: 315-425-4400 |
Sarah Wurz, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Erie Blvd E, Syracuse, NY 13224 Phone: 315-449-1016 Fax: 315-449-2666 |
Wiilliam Fry Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Pharmacy Dept, Syracuse, NY 13210 Phone: 315-425-4400 |
Jared Andrew Reles, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2329 James St, Syracuse, NY 13206 Phone: 315-437-0893 Fax: 315-438-3129 |
Rosemary Sovocool, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 736 Irving Ave, Syracuse, NY 13210 Phone: 315-470-7111 |
Mrs. Jacqueline S Empey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1820 Teall Ave, Syracuse, NY 13206 Phone: 315-437-1531 |
Kelly Gadomski, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 922 Spencer St, Syracuse, NY 13204 Phone: 315-492-1964 Fax: 315-469-9744 |
Mr. Rajan Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Gifford St, Syracuse, NY 13204 Phone: 315-471-4139 Fax: 315-471-4155 |
Mrs. Mary E. Walsh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Irving Ave, Syracuse, NY 13210 Phone: 315-425-4400 Fax: 315-425-2452 |
News Archive
Scientists are reporting that so-called "thirdhand smoke" - the invisible remains of cigarette smoke that deposits on carpeting, clothing, furniture and other surfaces - may be even more of a health hazard than previously believed. The study, published in ACS' journal, Environmental Science & Technology, extends the known health risks of tobacco among people who do not smoke but encounter the smoke exhaled by smokers or released by smoldering cigarette butts.
Robert Wood Johnson Foundation: The Secrets of Massachusetts' Success - "By the summer of 2008, less than two years after Massachusetts' health reform law became effective, only 2.6 percent of state residents were uninsured—the lowest proportion ever recorded for any state." This study by the RWJF-funded State Health Access Reform Evaluation (SHARE) initiative "explains how national reforms can use similar methods to avoid the pitfalls that have plagued other coverage expansions."
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
A new research technique, pioneered by Dr. Maria Angela Franceschini, will be published in JoVE (Journal of Visualized Experiments) on March 14th. Researchers at Massachusetts General Hospital and Harvard Medical School have developed a non-invasive optical measurement system to monitor neonatal brain activity via cerebral metabolism and blood flow.
Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva) compared to those who did not receive the drug according to new data being presented at the ASCO1 conference today (Monday).
› Verified 6 days ago